Your browser doesn't support javascript.
loading
The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.
van Baar, Michaël J B; van der Aart, Annemarie B; Hoogenberg, Klaas; Joles, Jaap A; Heerspink, Hiddo J L; van Raalte, Daniël H.
Afiliação
  • van Baar MJB; Department of Internal Medicine, Amsterdam University Medical Centers, VUMC, Amsterdam, The Netherlands.
  • van der Aart AB; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
  • Hoogenberg K; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.
  • Joles JA; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
  • van Raalte DH; Amsterdam University Medical Centers, VUMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Ther Adv Endocrinol Metab ; 10: 2042018819865398, 2019.
Article em En | MEDLINE | ID: mdl-31384419
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article